Cargando…

Interferon lambda rs368234815 ΔG/ΔG is associated with higher CD4(+):CD8(+) T-cell ratio in treated HIV-1 infection

BACKGROUND: The objectives of this study were to investigate the relationships between polymorphisms at the interferon lambda (IFNL) locus and CD4(+):CD8(+) ratio normalisation in people living with HIV (PLWH) on effective antiretroviral therapy (ART); and to examine whether these polymorphisms infl...

Descripción completa

Detalles Bibliográficos
Autores principales: Freitas, Inês T., Tinago, Willard, Sawa, Hirofumi, McAndrews, Julie, Doak, Brenda, Prior-Fuller, Charlotte, Sheehan, Gerard, Lambert, John S., Muldoon, Eavan, Cotter, Aoife G., Hall, William W., Mallon, Patrick W. G., Carr, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194102/
https://www.ncbi.nlm.nih.gov/pubmed/32295609
http://dx.doi.org/10.1186/s12981-020-00269-0
_version_ 1783528301578420224
author Freitas, Inês T.
Tinago, Willard
Sawa, Hirofumi
McAndrews, Julie
Doak, Brenda
Prior-Fuller, Charlotte
Sheehan, Gerard
Lambert, John S.
Muldoon, Eavan
Cotter, Aoife G.
Hall, William W.
Mallon, Patrick W. G.
Carr, Michael J.
author_facet Freitas, Inês T.
Tinago, Willard
Sawa, Hirofumi
McAndrews, Julie
Doak, Brenda
Prior-Fuller, Charlotte
Sheehan, Gerard
Lambert, John S.
Muldoon, Eavan
Cotter, Aoife G.
Hall, William W.
Mallon, Patrick W. G.
Carr, Michael J.
author_sort Freitas, Inês T.
collection PubMed
description BACKGROUND: The objectives of this study were to investigate the relationships between polymorphisms at the interferon lambda (IFNL) locus and CD4(+):CD8(+) ratio normalisation in people living with HIV (PLWH) on effective antiretroviral therapy (ART); and to examine whether these polymorphisms influence the composition of T lymphocyte compartments in long-term treated HIV-1 infection. METHODS: A cross-sectional study in PLWH enrolled into the Mater Immunology study. We performed IFNL genotyping on stored samples and evaluated the association of IFNL single-nucleotide polymorphisms (rs368234815 and rs12979860) with CD4(+):CD8(+) ratio normalization (> 1) and expanded CD4(+) and CD8(+) T-cell subsets; CD45RO(+)CD62L(+) (central-memory), CD45RO(+) CD62L(−)(effector-memory) and CD45RO(−)CD62L(+) (naïve), using logistic and linear regression models, respectively. RESULTS: 190 ambulatory PLWH recruited to the main study, 143 were included in the analysis (38 had no stored DNA and 9 no T-lymphocyte subpopulation). Of 143 included, the median age (IQR) was 45(39–48) years, 64% were male and 66% were of Caucasian ethnicity. Heterosexual-contact (36%), injecting drug-use (33%) and men who have sex with men (24%) were the most presented HIV-transmission risk groups. The majority of subjects (90.2%) were on ART with 79% of the cohort having an undetectable HIV-RNA (< 40 copies/ml) and the time since ART initiation was 7.5 (3.7–10.4) year. rs368234815 and rs12979860 displayed similar allelic frequencies, with minor alleles ΔG and T representing 39% and 42%, respectively, of circulating alleles. rs368234815 ΔG/ΔG minor homozygotes were significantly associated with increased odds for attaining a normalised CD4(+):CD8(+) ratio compared to rs368234815 T/T major homozygotes in PLWH virologically suppressed on effective ART (OR = 3.11; 95% CI [1.01:9.56]). rs368234815 ΔG/ΔG homozygosity was also significantly associated with lower levels of CD4(+) effector memory T-cells (regression coefficient: − 7.1%, p = 0.04) and CD8(+) naïve T-cell subsets were significantly higher in HIV-1 mono-infected PLWH with rs368234815 ΔG/ΔG (regression coefficient: + 7.2%, p = 0.04). CONCLUSIONS: In virally-suppressed, long-term ART-treated PLWH, rs368234815 ΔG/ΔG homozygotes were more likely to have attained normalisation of their CD4(+):CD8(+) ratio, displayed lower CD4(+) effector memory and higher naive CD8(+) T-cells. Further studies are needed to replicate our findings in other, larger and more diverse cohorts and to determine the impact of IFNL genetic-variation on CD4(+):CD8(+) ratio normalisation and clinical outcomes in PLWH.
format Online
Article
Text
id pubmed-7194102
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-71941022020-05-06 Interferon lambda rs368234815 ΔG/ΔG is associated with higher CD4(+):CD8(+) T-cell ratio in treated HIV-1 infection Freitas, Inês T. Tinago, Willard Sawa, Hirofumi McAndrews, Julie Doak, Brenda Prior-Fuller, Charlotte Sheehan, Gerard Lambert, John S. Muldoon, Eavan Cotter, Aoife G. Hall, William W. Mallon, Patrick W. G. Carr, Michael J. AIDS Res Ther Research BACKGROUND: The objectives of this study were to investigate the relationships between polymorphisms at the interferon lambda (IFNL) locus and CD4(+):CD8(+) ratio normalisation in people living with HIV (PLWH) on effective antiretroviral therapy (ART); and to examine whether these polymorphisms influence the composition of T lymphocyte compartments in long-term treated HIV-1 infection. METHODS: A cross-sectional study in PLWH enrolled into the Mater Immunology study. We performed IFNL genotyping on stored samples and evaluated the association of IFNL single-nucleotide polymorphisms (rs368234815 and rs12979860) with CD4(+):CD8(+) ratio normalization (> 1) and expanded CD4(+) and CD8(+) T-cell subsets; CD45RO(+)CD62L(+) (central-memory), CD45RO(+) CD62L(−)(effector-memory) and CD45RO(−)CD62L(+) (naïve), using logistic and linear regression models, respectively. RESULTS: 190 ambulatory PLWH recruited to the main study, 143 were included in the analysis (38 had no stored DNA and 9 no T-lymphocyte subpopulation). Of 143 included, the median age (IQR) was 45(39–48) years, 64% were male and 66% were of Caucasian ethnicity. Heterosexual-contact (36%), injecting drug-use (33%) and men who have sex with men (24%) were the most presented HIV-transmission risk groups. The majority of subjects (90.2%) were on ART with 79% of the cohort having an undetectable HIV-RNA (< 40 copies/ml) and the time since ART initiation was 7.5 (3.7–10.4) year. rs368234815 and rs12979860 displayed similar allelic frequencies, with minor alleles ΔG and T representing 39% and 42%, respectively, of circulating alleles. rs368234815 ΔG/ΔG minor homozygotes were significantly associated with increased odds for attaining a normalised CD4(+):CD8(+) ratio compared to rs368234815 T/T major homozygotes in PLWH virologically suppressed on effective ART (OR = 3.11; 95% CI [1.01:9.56]). rs368234815 ΔG/ΔG homozygosity was also significantly associated with lower levels of CD4(+) effector memory T-cells (regression coefficient: − 7.1%, p = 0.04) and CD8(+) naïve T-cell subsets were significantly higher in HIV-1 mono-infected PLWH with rs368234815 ΔG/ΔG (regression coefficient: + 7.2%, p = 0.04). CONCLUSIONS: In virally-suppressed, long-term ART-treated PLWH, rs368234815 ΔG/ΔG homozygotes were more likely to have attained normalisation of their CD4(+):CD8(+) ratio, displayed lower CD4(+) effector memory and higher naive CD8(+) T-cells. Further studies are needed to replicate our findings in other, larger and more diverse cohorts and to determine the impact of IFNL genetic-variation on CD4(+):CD8(+) ratio normalisation and clinical outcomes in PLWH. BioMed Central 2020-04-15 /pmc/articles/PMC7194102/ /pubmed/32295609 http://dx.doi.org/10.1186/s12981-020-00269-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Freitas, Inês T.
Tinago, Willard
Sawa, Hirofumi
McAndrews, Julie
Doak, Brenda
Prior-Fuller, Charlotte
Sheehan, Gerard
Lambert, John S.
Muldoon, Eavan
Cotter, Aoife G.
Hall, William W.
Mallon, Patrick W. G.
Carr, Michael J.
Interferon lambda rs368234815 ΔG/ΔG is associated with higher CD4(+):CD8(+) T-cell ratio in treated HIV-1 infection
title Interferon lambda rs368234815 ΔG/ΔG is associated with higher CD4(+):CD8(+) T-cell ratio in treated HIV-1 infection
title_full Interferon lambda rs368234815 ΔG/ΔG is associated with higher CD4(+):CD8(+) T-cell ratio in treated HIV-1 infection
title_fullStr Interferon lambda rs368234815 ΔG/ΔG is associated with higher CD4(+):CD8(+) T-cell ratio in treated HIV-1 infection
title_full_unstemmed Interferon lambda rs368234815 ΔG/ΔG is associated with higher CD4(+):CD8(+) T-cell ratio in treated HIV-1 infection
title_short Interferon lambda rs368234815 ΔG/ΔG is associated with higher CD4(+):CD8(+) T-cell ratio in treated HIV-1 infection
title_sort interferon lambda rs368234815 δg/δg is associated with higher cd4(+):cd8(+) t-cell ratio in treated hiv-1 infection
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194102/
https://www.ncbi.nlm.nih.gov/pubmed/32295609
http://dx.doi.org/10.1186/s12981-020-00269-0
work_keys_str_mv AT freitasinest interferonlambdars368234815dgdgisassociatedwithhighercd4cd8tcellratiointreatedhiv1infection
AT tinagowillard interferonlambdars368234815dgdgisassociatedwithhighercd4cd8tcellratiointreatedhiv1infection
AT sawahirofumi interferonlambdars368234815dgdgisassociatedwithhighercd4cd8tcellratiointreatedhiv1infection
AT mcandrewsjulie interferonlambdars368234815dgdgisassociatedwithhighercd4cd8tcellratiointreatedhiv1infection
AT doakbrenda interferonlambdars368234815dgdgisassociatedwithhighercd4cd8tcellratiointreatedhiv1infection
AT priorfullercharlotte interferonlambdars368234815dgdgisassociatedwithhighercd4cd8tcellratiointreatedhiv1infection
AT sheehangerard interferonlambdars368234815dgdgisassociatedwithhighercd4cd8tcellratiointreatedhiv1infection
AT lambertjohns interferonlambdars368234815dgdgisassociatedwithhighercd4cd8tcellratiointreatedhiv1infection
AT muldooneavan interferonlambdars368234815dgdgisassociatedwithhighercd4cd8tcellratiointreatedhiv1infection
AT cotteraoifeg interferonlambdars368234815dgdgisassociatedwithhighercd4cd8tcellratiointreatedhiv1infection
AT hallwilliamw interferonlambdars368234815dgdgisassociatedwithhighercd4cd8tcellratiointreatedhiv1infection
AT mallonpatrickwg interferonlambdars368234815dgdgisassociatedwithhighercd4cd8tcellratiointreatedhiv1infection
AT carrmichaelj interferonlambdars368234815dgdgisassociatedwithhighercd4cd8tcellratiointreatedhiv1infection